Kura Oncology grants options for 55,500 shares to three new employees

Kura Oncology granted nonstatutory stock options covering 55,500 common shares to three new employees on November 2, 2026. The options vest over four years, starting with 25% on the first anniversary of each employee’s commencement date and the remainder monthly over 36 months, subject to continued service.